C92.6UpcomingCategory · further specificity required

Acute myeloid leukemia with 11q23-abnormality

C92 · Inherited instructions

Code also

, if applicable, pancytopenia (acquired) (D61.818)

Excludes 1

personal history of leukemia (Z85.6)

Excludes 2 · 4

C81-C96 · Malignant neoplasms of lymphoid, hematopoietic and related tissue (C81-C96)

Excludes 2

Kaposi's sarcoma of lymph nodes (C46.3)
secondary and unspecified neoplasm of lymph nodes (C77.-)
secondary neoplasm of bone marrow (C79.52)
secondary neoplasm of spleen (C78.89)

More specific codes

C92.60Acute myeloid leukemia with 11q23-abnormality not having achieved remission C92.61Acute myeloid leukemia with 11q23-abnormality in remission C92.62Acute myeloid leukemia with 11q23-abnormality in relapse

Claims & coverage

When ICD-10-CM is required

For US diagnosis claims covered by HIPAA, ICD-10-CM is required from October 1, 2015.

Use the service date for outpatient/professional claims and the discharge date for hospital inpatient claims. Earlier encounters use ICD-9-CM; each individual code must also be valid for the applicable date.

Official coding guidelines → · CMS ↗

First observed · 2015-10-01

Code history

Latest recorded change · FY2024

ChangedUnchanged

FY2024

Effective from 2023-10-01

Inherited rules changed

Acute myeloid leukemia with 11q23-abnormality

Category — select a more specific code

CDC/NCHS · FY2024

All editions (19)

All editions	Effective from	Code history
FY2016	2015-10-01	First observed
FY2017	2016-10-01	No tabular change
FY2018	2017-10-01	No tabular change
FY2019	2018-10-01	No tabular change
FY2020	2019-10-01	No tabular change
FY2020 · April	2020-04-01	No tabular change
FY2021	2020-10-01	No tabular change
FY2021 · 01-01	2021-01-01	No tabular change
FY2022	2021-10-01	No tabular change
FY2022 · 04-01	2022-04-01	No tabular change
FY2023	2022-10-01	No tabular change
FY2023 · 04-01	2023-04-01	No tabular change
FY2024	2023-10-01	Inherited rules changed
FY2024 · 04-01	2024-04-01	No tabular change
FY2025	2024-10-01	No tabular change
FY2025 · 04-01	2025-04-01	No tabular change
FY2026	2025-10-01	No tabular change
FY2026 · April	2026-04-01	No tabular change
FY2027	2026-10-01	No tabular change

Code-level instructions

Inclusion terms

Acute myeloid leukemia with variation of MLL-gene

Inherited instructions

Chapters 2 · Neoplasms (C00-D49)

Note

Functional activity
All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm.
Morphology [Histology]
Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes.
Primary malignant neoplasms overlapping site boundaries
A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned.
Malignant neoplasm of ectopic tissue
Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (C25.9).

C81-C96 · Malignant neoplasms of lymphoid, hematopoietic and related tissue (C81-C96)

Excludes 2

Kaposi's sarcoma of lymph nodes (C46.3)
secondary and unspecified neoplasm of lymph nodes (C77.-)
secondary neoplasm of bone marrow (C79.52)
secondary neoplasm of spleen (C78.89)

C92 · Myeloid leukemia

Includes

granulocytic leukemia
myelogenous leukemia

Excludes 1

personal history of leukemia (Z85.6)

Code also

, if applicable, pancytopenia (acquired) (D61.818)

More specific codes

C92.60Acute myeloid leukemia with 11q23-abnormality not having achieved remissionBillable / specific C92.61Acute myeloid leukemia with 11q23-abnormality in remissionBillable / specific C92.62Acute myeloid leukemia with 11q23-abnormality in relapseBillable / specific

Official index references (2)

Leukemia, leukemic (2)

Leukemia, leukemic › acute myeloid, NOS › with › 11q23-abnormalityDisease index
Leukemia, leukemic › acute myeloid, NOS › with › variation of MLL-geneDisease index

Related codes

Other entries in the same category; these are not automatic substitutes.

Code	Description	Category · further specificity required
C92.0	Acute myeloblastic leukemia	Category · further specificity required
C92.1	Chronic myeloid leukemia, BCR/ABL-positive	Category · further specificity required
C92.2	Atypical chronic myeloid leukemia, BCR/ABL-negative	Category · further specificity required
C92.3	Myeloid sarcoma	Category · further specificity required
C92.4	Acute promyelocytic leukemia	Category · further specificity required
C92.5	Acute myelomonocytic leukemia	Category · further specificity required
C92.9	Myeloid leukemia, unspecified	Category · further specificity required
C92.A	Acute myeloid leukemia with multilineage dysplasia	Category · further specificity required
C92.Z	Other myeloid leukemia	Category · further specificity required

Official titles and instructions are preserved in their source language. Official sources ↗

References from other codes (1)

D47.02 · Systemic mastocytosis

Code also · acute myeloid leukemia (C92.6-, C92.A-)